These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1010602)

  • 1. The distance between the contact sites for DNP and menadione ligands in the combining region of myeloma proteins binding both haptens--II. Estimation of distance using haptenic probes with variable length spacers.
    Rosenstein RW; Richards FF
    Immunochemistry; 1976 Nov; 13(11):939-43. PubMed ID: 1010602
    [No Abstract]   [Full Text] [Related]  

  • 2. The distance between the contact sites for DNP and menadione ligands in the combining region of myeloma proteins binding both haptens--I. Estimation of distance by fluorescent energy transfer in protein 460.
    Manjula BN; Richards FF; Rosenstein RW
    Immunochemistry; 1976 Nov; 13(11):929-37. PubMed ID: 1010601
    [No Abstract]   [Full Text] [Related]  

  • 3. Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.
    Kumar K; Phelps DJ; Carey PR; Young NM
    Biochem J; 1978 Nov; 175(2):727-35. PubMed ID: 743221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of an antibody combining site by magnetic resonance.
    Dwek RA; Wain-Hobson S; Dower S; Gettins P; Sutton B; Perkins SJ; Givol D
    Nature; 1977 Mar; 266(5597):31-7. PubMed ID: 190543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies.
    Michaelides MC; Eisen HN
    J Exp Med; 1974 Sep; 140(3):687-702. PubMed ID: 4138007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactions between 2, 4-dinitrophenyl and menadione (vitamin K3) and the general problem of antibody specificity.
    Johnston MF; Eisen HN
    J Immunol; 1976 Oct; 117(4):1189-96. PubMed ID: 789769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the specificity of antibodies.
    Richards FF; Konigsberg WH; Rosenstein RW; Varga JM
    Science; 1975 Jan; 187(4172):130-7. PubMed ID: 46122
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison by 1H NMR of the hapten environment in the combining site of the dinitrophenyl binding IgA protein 315 and its fragments.
    Morris AT; Givol D; Dwek RA
    Immunochemistry; 1978 Aug; 15(8):519-22. PubMed ID: 730222
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen-binding myeloma proteins of mice.
    Potter M
    Adv Immunol; 1977; 25():141-211. PubMed ID: 76433
    [No Abstract]   [Full Text] [Related]  

  • 10. Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315.
    Padlan EA; Davies DR; Pecht I; Givol D; Wright C
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 2():627-37. PubMed ID: 268248
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for multispecificity of antibody molecules.
    Cameron DJ; Erlanger BF
    Nature; 1977 Aug; 268(5622):763-5. PubMed ID: 70759
    [No Abstract]   [Full Text] [Related]  

  • 12. Arginine as a contact residue in the hapten-binding site of protein 315.
    Klostergaard J; Krausz LM; Grossberg AL; Pressman D
    Immunochemistry; 1977 Feb; 14(2):107-10. PubMed ID: 852884
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. I. Mapping of genes for Id-460 expression to the variable region of immunoglobulin heavy-chain locus and to the variable region of immunoglobulin kappa-light-chain locus.
    Dzierzak EA; Janeway CA; Rosenstein RW; Gottlieb PD
    J Exp Med; 1980 Sep; 152(3):720-9. PubMed ID: 6774049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nitro groups in the binding of nitroaromatics to protein MOPC 315.
    Gettins P; Givol D; Dwek RA
    Biochem J; 1978 Sep; 173(3):713-22. PubMed ID: 708369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The location and expression of idiotypic determinants in the immunoglobulin variable region--III. Expression of the protein 315 and 460 idiotypic determinants in mouse anti-Dnp antibodies.
    Zeldis JB; Riblet R; Konigsberg WH; Richards FF; Rosenstein RW
    Mol Immunol; 1979 Sep; 16(9):657-64. PubMed ID: 93694
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping.
    Willan KJ; Marsh D; Sunderland CA; Sutton BJ; Wain-Hobson S; Dwek RA; Givol D
    Biochem J; 1977 Aug; 165(2):199-206. PubMed ID: 200220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies in solution on the combining site of the myeloma protein MOPC 315.
    Dwek RA
    Contemp Top Mol Immunol; 1977; 6():1-52. PubMed ID: 232031
    [No Abstract]   [Full Text] [Related]  

  • 18. The idiotypic network: the murine MOPC315 anti-DNP system.
    Amor M; Mariamé B; Voegtlé D; Cazenave PA
    Ann Immunol (Paris); 1982; 133D(3):255-62. PubMed ID: 6984635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations of IgG1 anti-DNP hybridoma-mediated ADCC and the failure of three IgM anti-DNP hybridomas to mediate ADCC.
    Greenberg AH; Lydyard PM
    J Immunol; 1979 Aug; 123(2):861-9. PubMed ID: 458155
    [No Abstract]   [Full Text] [Related]  

  • 20. Parallel expression of new idiotypes on T and B cells.
    Julius MH; Cosenza H; Augustin AA
    Nature; 1977 Jun; 267(5610):437-9. PubMed ID: 69272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.